Disclosures The faculty reported the following relevant financial - - PowerPoint PPT Presentation

Disclosures

The faculty reported the following relevant financial relationships during the content development process for this activity: Sahil A. Parikh, MD, FSCAI Abbott (St. Jude): Advisory Board; Asahi: Consulting; Boston Scientific: Advisory Board; Cardiovascular Systems, Inc.: Advisory Board; Heartflow: Consulting, Speakers Bureau; Medtronic: Advisory Board; Merril Lifesciences: Consulting; Shockwave Medical: Principal Investigator; Silk Road Medical: DSMB; Terumo: Consulting; TriReme Medical: Principal Investigator Mohammad A. Ansari, MD, FSCAI Nothing to disclose. Jihad A. Mustapha, MD, FSCAI Bard Peripheral Vascular: Consulting; Boston Scientific: Consulting; CardioFlow: Ownership Interests (Stocks, Stock Options); Medtronic: Consulting; Philips: Consulting; Terumo: Consulting Ramzan Zakir, MD, FSCAI Abbott (St. Jude): Consulting; Boston Scientific: Advisory Board, Consulting, Speakers Bureau; Cardiovascular Systems, Inc.: Consulting Sanjum Sethi, MD, MPH Nothing to disclose. CME Oversight Committee reviewers Waqar H. Ahmed, MD, MS, FSCAI, and Babu Ezhumalai, MD, DM, FNB, FSCAI, reported no financial relationships. SCAI staff associated with the development of content for this activity, Robert Bartel, MSc, FACEHP, and Laura Daigle Porter, CMP, reported no relevant financial relationships.

Accreditation Statement

The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SCAI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

• Upon completion of this activity, participants will be able to:
• Define the changing landscape for critical limb ischemia (CLI) diagnosis and

treatment.

• Review crossing devices and techniques for SFA and tibial chronic total
• cclusions.
• Discuss the role of atherectomy below the knee.
• Individualize patient treatment from available therapies for CLI

Evaluation and Certificates

• Evaluations are available through the SCAI 2019 app.
• Please claim credit within 30 days of the meeting.

Agenda

Moderator: Sahil A. Parikh, MD, FSCAI Time to Redefine Critical Limb Ischemia Case 1: Perfusion Challenges Sahil A. Parikh, MD, FSCAI Access and Crossing Techniques Case 2: Crossing CTOs Mohammad M. Ansari, MD Debulking Below the Knee: Devices and Techniques Case 3: Atherectomy Jihad A. Mustapha, MD, FSCAI Distal Foot Reconstruction: Why and How Case 4: Pedal Disease Ramzan Zakir, MD, FSCAI How to Address Complex Popliteal Disease in a Patient with Significant Below the Knee Disease: My Approach Case 5: Complex SFA/POP in a CLI Patient Sanjum Sethi, MD, MPH